Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Clasificación en acciones #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Precio por acción
$0.00244926
Capitalización bursátil
$51.67K
Cambio (1 día)
5.88%
Cambio (1 año)
110.15%
País
GB
Comercio Nuformix plc (NFX)

Categoría

Historial del precio de la acción de Nuformix plc (NFX)
Precio más alto de cierre: $0.00 el 2026-03-01

Precio más bajo de cierre: $0.04 el 2015-12-01
Historial del precio de la acción de Nuformix plc desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 411.32%
2024 -82.51%
2023 -11.70%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$36.04 -48.63%
DK
$433.07 -13.83%
US
$737.71 16.02%
US
$298.91 66.79%
BE
$100.99 -36.10%
AU